You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Orsiro drug eluting stent

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Orsiro™ Drug Eluting Stent in Routine Clinical Practice

Active, not recruiting
  • Angioplasty, Transluminal, Percutaneous Coronary
  • Coronary Artery Disease
  • Orsiro™ Drug Eluting Stent group
  • Anyang, Korea, Republic of
  • +17 more
Dec 11, 2022

Coronary Artery Disease Trial in Taoyuan (Orsiro stent, Xience stent, Any drug-eluting stent)

Not yet recruiting
  • Coronary Artery Disease
  • Orsiro stent
  • +2 more
  • Taoyuan, Taiwan
    Linkou Chang Gung Memorial Hospital
Jan 16, 2022

Coronary Disease, Coronary Stenoses Trial in Korea, Republic of (quantitative coronary angiography guided coronary intervention

Active, not recruiting
  • Coronary Disease
  • Coronary Stenoses
  • quantitative coronary angiography guided coronary intervention with sirolimus-eluting Orsiro/Orsiro mission stent
  • intravascular ultrasound guided coronary intervention with sirolimus-eluting Orsiro/Orsiro mission stent
  • Anam, Korea, Republic of
  • +8 more
Mar 1, 2022

High Bleeding Risk, Coronary Artery Disease (CAD), Percutaneous Coronary Intervention (PCI) Trial in Ciudad de México (Drug

Terminated
  • High Bleeding Risk
  • +2 more
  • Drug Eluting Balloon (DEB)
  • Drug Eluting Stents (DES)
  • Ciudad de México, Mexico
    Instituto Nacional de Cardiologia "Ignacio Chávez"
Oct 19, 2021

BIOFLOW-china Post-marketing Study (BIOTRONIK)

Not yet recruiting
  • In-Stent Stenosis (Restenosis) of Coronary Artery Stent
  • Native Coronary Artery Stenosis
  • BIOTRONIK Orsiro Sirolimus-Eluting Coronary Stent System
  • Harbin, Heilongjiang, China
    The Fourth Affiliated Hospital of Harbin Medical University
Dec 26, 2022

Coronary Artery Disease, Coronary Stenosis, Stent Restenosis Trial in Torino (Percutaneous coronary intervention with the

Recruiting
  • Coronary Artery Disease
  • +4 more
  • Percutaneous coronary intervention with the following platforms: Orsiro; Mistent; BioMime; Supraflex Cruz
  • Torino, Italy
    Fabrizio D'Ascenzo
Jan 19, 2022

In-stent Restenosis Trial (Drug-eluting Coronary Spur Stent System)

Not yet recruiting
  • In-stent Restenosis
  • Drug-eluting Coronary Spur Stent System
  • (no location specified)
Oct 31, 2023

Coronary Artery Disease, Ischemic Heart Disease Trial in Odense (Drug-eluting stent)

Active, not recruiting
  • Coronary Artery Disease
  • Ischemic Heart Disease
  • Drug-eluting stent
  • Odense, Denmark
    Odense University Hospital
Sep 17, 2020

Critical Limb Ischemia Trial (Drug Eluting Temporary Spur Stent System, Percutaneous Transluminal Balloon Angioplasty)

Not yet recruiting
  • Critical Limb Ischemia
  • Drug Eluting Temporary Spur Stent System
  • Percutaneous Transluminal Balloon Angioplasty
  • (no location specified)
Nov 8, 2023

Diabetes, Coronary Artery Disease, Acute Coronary Syndrome Trial in Mexico City (Abluminus Sirolimus Eluting Stent System

Recruiting
  • Diabetes Mellitus
  • +2 more
  • Abluminus Sirolimus Eluting Stent System (ASES)
  • Orsiro Sirolimus Eluting Coronary Stent System (OSES)
  • Mexico City, Tlalpan, Mexico
    Instituto Nacional de Cardiología Ignacio Chávez
Mar 8, 2022

Drug-eluting Stent, Coronary Artery Disease Trial in Suwon (Genoss® DES system, Genoss® Osfit system)

Recruiting
  • Drug-eluting Stent
  • Coronary Artery Disease
  • Genoss® DES system, Genoss® Osfit system
  • Suwon, Korea, Republic of
    Ajou University Hospital
Sep 27, 2023

Restenosis Trial in Ostrava (paclitaxel-coated balloon catheter with Iopromide coating, drug eluting stent with everolimus,

Completed
  • Restenosis
  • paclitaxel-coated balloon catheter with Iopromide coating
  • +2 more
  • Ostrava, Czechia
    University Hospital
Dec 6, 2022

Propel Drug-Eluting Sinus Stent Family

Recruiting
  • Chronic Rhinosinusitis (Diagnosis)
  • NA-Observational Registry
  • Wiesbaden, Germany
    Helios Dr Horst Schmidt Kliniken
Jun 19, 2023

Peripheral Artery Disease Trial in Shanghai (Drug eluting stent, drug coating balloon)

Recruiting
  • Peripheral Artery Disease
  • Drug eluting stent
  • drug coating balloon
  • Shanghai, Shanghai, China
    Changhai Hospital of Shanghai
Mar 20, 2023

Chronic Coronary Syndrome Trial (Magic Touch drug eluting balloon based strategy, Drug-eluting stent-based strategy)

Not yet recruiting
  • Chronic Coronary Syndrome
  • Magic Touch drug eluting balloon based strategy
  • Drug-eluting stent-based strategy
  • (no location specified)
Jan 5, 2023

Coronary Artery Disease, Restenoses, Coronary Trial in Munich (Drug eluting stent (DES), Drug coated ballloon (DCB))

Recruiting
  • Coronary Artery Disease
  • Restenoses, Coronary
  • Drug eluting stent (DES)
  • Drug coated ballloon (DCB)
  • Munich, Germany
    Deutsches Herzzentrum München
Oct 12, 2022

Atherosclerosis, Ischemia Trial in Beijing (Drug-eluting Stent, Excimer Laser Ablation Combined Drug-coated Balloon)

Withdrawn
  • Atherosclerosis
  • Ischemia
  • Drug-eluting Stent
  • Excimer Laser Ablation Combined Drug-coated Balloon
  • Beijing, Beijing, China
    Gu Yong Quan
Dec 4, 2022

Drug-coated Balloon, Drug-eluting Stent, De Novo Stenosis Trial in Beijing (Drug-coated balloon (Bingo© [Paclitaxel-coated

Recruiting
  • Drug-coated Balloon
  • +2 more
  • Drug-coated balloon (Bingo© [Paclitaxel-coated Balloon], Yinyi Ltd., China)
  • Drug-eluting stent
  • Beijing, China
    Fuwai Hospital, National Center for Cardiovascular Diseases，Chin
Oct 14, 2023

Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent Trial in Beijing (24 Months DAPT, 12 Months DAPT)

Not yet recruiting
  • Elevated Lipoprotein(a) Level
  • +3 more
  • 24 Months DAPT
  • 12 Months DAPT
  • Beijing, Beijing, China
    Fuwai Hospital, National Center for Cardiovascular Diseases, Chi
Aug 26, 2023

Coronary Artery Disease, Ischemic Heart Disease Trial in Suwon (Procedure: planed 2-stent strategy, Procedure: provisional

Recruiting
  • Coronary Artery Disease
  • Ischemic Heart Disease
  • Procedure: planed 2-stent strategy
  • Procedure: provisional 1-stent plus DEB strategy
  • Suwon, Gyeonggi-do, Korea, Republic of
    St. Vincent's Hospital , the Catholic University
Aug 17, 2023

Orsiro Sirolimus Eluting Coronary Stent System in Coronary

Active, not recruiting
  • Coronary Artery Disease
  • +5 more
  • Orsiro DES
  • Fairhope, Alabama
  • +32 more
Mar 1, 2022

Intracranial Arteriosclerosis, Stenosis Artery, Drug-Eluting Stents Trial (Drug-Eluting Stents)

Not yet recruiting
  • Intracranial Arteriosclerosis
  • +3 more
  • Drug-Eluting Stents
  • (no location specified)
Jan 11, 2023

Coronary Stent Restenosis Trial in Szeged, Budapest (Intravascular management of prior implanted coronary drug eluting stent

Recruiting
  • Coronary Stent Restenosis
  • Intravascular management of prior implanted coronary drug eluting stent restenosis
  • Szeged, Csongád-Csanád, Hungary
  • +1 more
Jun 27, 2022

Coronary Artery Disease, Coronary Bifurcation Lesion Trial in Eindhoven (Hybrid DEB approach with drug-eluting balloon,

Not yet recruiting
  • Coronary Artery Disease
  • Coronary Bifurcation Lesion
  • Hybrid DEB approach with drug-eluting balloon
  • Two-stent strategy
  • Eindhoven, North- Brabant, Netherlands
    Catharina Hospital
Feb 7, 2023

Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome Trial in Worldwide (SeQuent® Please NEO drug-coated

Not yet recruiting
  • Coronary Artery Disease
  • +4 more
  • SeQuent® Please NEO drug-coated balloon catheter
  • Current-generation drug-eluting stent
  • Chuncheon, Gangwon-do, Korea, Republic of
  • +5 more
Apr 26, 2023